Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Acute Treatment in First Episode Schizophrenic Patients by New Pharmacological Treatments

NCT00157378 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.

NCT NCT00157378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Acute Treatment in First Episode Schizophrenic Patients by New Pharmacological Treatments
Lead sponsor
Ludwig-Maximilians - University of Munich
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2000
Completion date
December 31, 2004
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, first-episode